Hi! I would appreciate if you can provide some clarity on why 'dosage' information is considered non-clinical (when the dosage at which a drug has established efficacy/safety is of clinical relevance). Referring to your response to Q#451, it says " A product’s Health Canada approved indication and dosing is clinically relevant" and it proceeds to say that "Although an individual product’s indication and dosing info is clinically significant, the significance of the incremental difference in indication/dosing between multiple products is generally unknown". Hence from my understanding, this is implying that when speaking of your own drug's dosage it is 'clinical' information, but when comparing dosage of products from multiple TMAs it constitutes 'non-clinical' information. Please help clarify, thank you.
M
mef
@mef
Forum Update: Supporting Community-Led Discussion
The forum was created as a space for shared learning and peer support, and as the community grows, we want to lean more fully into that purpose.
Going forward, PAAB will be taking a more listening-first role in forum discussions. Rather than responding immediately to every question, we’ll be encouraging members to engage with one another, share experiences, and help build collective understanding. PAAB will continue to monitor conversations and will step in to:
- Correct any misunderstandings
- Provide guidance when questions remain unanswered after a few days
- Support discussions where official clarification is needed
Our goal is to foster a collaborative, trusted community where knowledge is shared and strengthened by everyone’s contributions.
Thank you for being part of the conversation.